Stanford University is home to the Vera Moulton Wall Center for Pulmonary Vascular Disease, directed by
Dr. Jeffrey Feinstein. This program, launched in 2000, is a major program for the treatment of pulmonary hypertension. One of
only a handful of programs in the nation with the ability to treat both children and adults with pulmonary hypertension, this program is growing rapidly and is bringing together an unprecedented constellation of expertise in this challenging field.
Dr. Marlene Rabinovitch is the Director of Research for the Wall Center. She is world-renowned for her work in the etiology and treatment of pulmonary hypertension and pulmonary vascular disease, and runs the
Rabinovitch/Bland basic science laboratory at Stanford.